Myopia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) >=6 years old and = 5.0 in both eyes; 6) The average daily near-eye use (reading, writing, using electronic devices such as cell phones, tablets, or computer screens) is>=1 hour; 7) Volunteer to participate in this clinical trial and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1) History of ocular surface and intraocular surgery due to organic ocular pathology; 2) Abnormal intraocular pressure ( 21mmHg, or difference in intraocular pressure between two eyes > 5mmHg); 3) Combination of other eye diseases, such as uveitis and other inflammatory diseases, glaucoma, cataracts, fundopathy, ocular tumors, and any ocular pathology that affects visual function; 4) Patients suffering from systemic diseases resulting in immunocompromise; 5) Those who are unable to undergo regular eye examinations; 6) Have participated or are currently participating in any myopia control clinical research trial within three months; 7) Have used or are now using any myopia control products such as keratoconus, multifocal contact lenses, multipoint defocus design myopia control spectacles, feeder lenses, and low-concentration atropine-based medications within three months; 8) Significant strabismus; 9) Those who are judged by the investigator to be ineligible for enrollment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| AL elongation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in objective SER under cycloplegia;anterior chamber depth;Crystal thickness;Corneal curvature;Choroidal thickness;Choroidal blood flow; | — |
Countries
China
Contacts
Eye Hospital of Wen Medical University